Partners sells majority stake in PCI Pharma to Kohlberg & Co; Blackstone snaps up Takeda’s Japanese consumer health unit; Branford strikes first Fund 2 investment

Takeda Pharmaceutical is divesting its Japanese consumer healthcare business to Blackstone Group and Branford Castle Partners buys Fibrix Filtration.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this